Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Biochemical and Biophysical Research Communications
|
June 15, 1992
A ring-reversed analog of atrial natriuretic peptide retains receptor binding, guanylate cyclase stimulation
T W von Geldern, G P Budzik, T P Dillon
Peptide Research
|
January 1, 1991
A fluorogenic assay for endothelin-converting enzyme
T W von Geldern, W H Holleman, T J Opgenorth
Biochimica Et Biophysica Acta
|
April 24, 1997
Stimulation of atrial natriuretic peptide receptor/guanylyl cyclase- A signaling pathway antagonizes the activation of protein kinase C-alpha in murine Leydig cells
R Kumar, T W von Geldern, R A Calle, et al.
The American Journal of Physiology
|
February 1, 1994
Atrial natriuretic peptide and glomerular hyperfiltration during onset of spontaneous diabetes mellitus
M I Okwueze, T J Opgenorth, T W von Geldern, et al.
The Journal of Biological Chemistry
|
October 25, 1996
An essential myosin light chain peptide induces supramaximal stimulation of cardiac myofibrillar ATPase activity
H M Rarick, T J Opgenorth, T W von Geldern, et al.
Life Sciences
|
January 1, 1996
Endothelins and endothelin receptor antagonists: binding to plasma proteins
J R Wu-Wong, W J Chiou, D J Hoffman, et al.
Journal of Medicinal Chemistry
|
November 5, 1997
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonists
H S Jae, M Winn, D B Dixon, et al.
Journal of Medicinal Chemistry
|
February 16, 1996
Azole endothelin antagonists. 2. Structure-activity studies
T W von Geldern, J A Kester, R Bal, et al.
Journal of Medicinal Chemistry
|
February 16, 1996
Azole endothelin antagonists. 1. A receptor model explains an unusual structure-activity profile
T W von Geldern, C Hutchins, J A Kester, et al.
Journal of Medicinal Chemistry
|
November 2, 2001
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ET(A) antagonists
H S Jae, M Winn, T W von Geldern, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Biochemical and Biophysical Research Communications
|
June 15, 1992
A ring-reversed analog of atrial natriuretic peptide retains receptor binding, guanylate cyclase stimulation
T W von Geldern, G P Budzik, T P Dillon
Peptide Research
|
January 1, 1991
A fluorogenic assay for endothelin-converting enzyme
T W von Geldern, W H Holleman, T J Opgenorth
Biochimica Et Biophysica Acta
|
April 24, 1997
Stimulation of atrial natriuretic peptide receptor/guanylyl cyclase- A signaling pathway antagonizes the activation of protein kinase C-alpha in murine Leydig cells
R Kumar, T W von Geldern, R A Calle, et al.
The American Journal of Physiology
|
February 1, 1994
Atrial natriuretic peptide and glomerular hyperfiltration during onset of spontaneous diabetes mellitus
M I Okwueze, T J Opgenorth, T W von Geldern, et al.
The Journal of Biological Chemistry
|
October 25, 1996
An essential myosin light chain peptide induces supramaximal stimulation of cardiac myofibrillar ATPase activity
H M Rarick, T J Opgenorth, T W von Geldern, et al.
Life Sciences
|
January 1, 1996
Endothelins and endothelin receptor antagonists: binding to plasma proteins
J R Wu-Wong, W J Chiou, D J Hoffman, et al.
Journal of Medicinal Chemistry
|
November 5, 1997
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonists
H S Jae, M Winn, D B Dixon, et al.
Journal of Medicinal Chemistry
|
February 16, 1996
Azole endothelin antagonists. 2. Structure-activity studies
T W von Geldern, J A Kester, R Bal, et al.
Journal of Medicinal Chemistry
|
February 16, 1996
Azole endothelin antagonists. 1. A receptor model explains an unusual structure-activity profile
T W von Geldern, C Hutchins, J A Kester, et al.
Journal of Medicinal Chemistry
|
November 2, 2001
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ET(A) antagonists
H S Jae, M Winn, T W von Geldern, et al.
Page
of 4